Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Vestronidase Alfa
Therapeutic Area : Rare Diseases and Disorders
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Mepsevii is a Enzyme drug candidate, which is currently being evaluated in clinical studies for the treatment of Mucopolysaccharidosis VII.
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
December 13, 2018
Lead Product(s) : Vestronidase Alfa
Therapeutic Area : Rare Diseases and Disorders
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable